
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
| Revenue (TTM) | $159.53M |
| Gross Profit (TTM) | $63.20M |
| EBITDA | -2,000 |
| Operating Margin | -1.10% |
| Return on Equity | 0.45% |
| Return on Assets | -0.78% |
| Revenue/Share (TTM) | $0.42 |
| Book Value | $2.85 |
| Price-to-Book | 1.00 |
| Price-to-Sales (TTM) | 6.68 |
| EV/Revenue | 1.607 |
| EV/EBITDA | 1.90 |
| Quarterly Earnings Growth (YoY) | 126.80% |
| Quarterly Revenue Growth (YoY) | 40.10% |
| Shares Outstanding | $373.66M |
| Float | $192.24M |
| % Insiders | 48.55% |
| % Institutions | 15.59% |
Volatility is currently contracting


Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding.

A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, the Company's notice of intention to make a normal course issuer bid (the “TSX NCIB”).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CRON and any ticker you trade — then tracks every position and per-strategy win rate.